Ischemic heart disease Board decisions

The Board granted service connection for diabetes mellitus, heart disease including myocarditis and pericarditis, hypertension, and pancreatitis as secondary to alcoholism due to the Veteran's service-connected PTSD. Service connection was also granted for left ear hearing loss and arthritis of the left hand on a direct basis.

The Board remands the matter to obtain potentially outstanding treatment records from Bay Medical Hospital.

The Board granted a motion to vacate its May 2021 decision and dismissed the claims for service connection due to the Veteran's death before the appeal was properly substituted.

The Board granted service connection for arteriosclerotic heart disease with CAD, diabetes mellitus type 2, left below knee amputation with left hip avascular necrosis, and an acquired psychiatric disorder due to the Veteran's service-connected status post left leg amputation.

The Veteran's coronary artery disease (CAD) has been productive of severe symptoms including dyspnea, fatigue, angina, and dizziness with a workload of 3 METs or less, warranting a total disability evaluation.

The Board denied service connection for a heart disability, to include IHD, but granted an earlier effective date of September 26, 2011, for the appellant's peripheral neuropathy of both upper extremities.

The Veteran's service-connected disabilities have rendered him unable to secure or follow substantially gainful employment from August 11, 2023.

The Board granted an earlier effective date of June 4, 2024, for CAD associated with herbicide exposure based on the PACT Act.

The Board denied the veteran's claims for increased ratings and service connection, finding no evidence to support higher ratings or a link between his claimed conditions and military service.

The Board granted an initial 100 percent rating for heart disease and special monthly compensation (SMC) based upon the need for regular aid and attendance of another person, while denying earlier effective dates for service connection for hypertension, heart disease, and left femoral nerve peripheral neuropathy.

The Board denied an initial compensable disability rating for skin cancer removal scars and remanded service connection claims for a respiratory disorder, heart disorder, and hypertension.

The Board granted an effective date of January 7, 2022, for the award of service connection for ischemic heart disease, hypertension, and tinnitus.

The Veteran's service-connected disabilities have rendered him unable to obtain and maintain gainful employment, warranting a total disability rating based on individual unemployability (TDIU).

The Board remands the claims for a kidney condition and heart condition due to a pre-decisional duty to assist error related to the failure to obtain Social Security Administration records.

The Board remands the claims for service connection for various conditions, including bilateral hearing loss, tinnitus, low back condition, COPD, brain condition, diabetes mellitus type II, GERD, heart condition, and hypertension, to obtain additional evidence.

The Board denied service connection for a disorder manifested by fatigue and a heart disorder, as there was no evidence of current disabilities related to these conditions during the pendency of the claim.

The Board granted service connection for a heart disability, to include bigeminy, and denied an initial compensable rating for allergic rhinitis.

The Board denied the Veteran's claims for increased ratings for obstructive sleep apnea, type II diabetes mellitus, atrial fibrillation with rapid ventricular rate, and hypertension. However, a 60 percent rating was granted for coronary artery disease effective May 24, 2023.

The Board granted an initial 40 percent rating for chronic lumbosacral strain with degenerative disk disease and left lower extremity peripheral neuropathy, and a separate 20 percent rating for right lower extremity peripheral neuropathy. The claims for increased ratings for the remaining conditions were denied.

The Veteran was granted an initial evaluation of 60 percent for coronary artery disease (CAD) from August 19, 2009, and earlier effective dates for TDIU and DEA. The claim for SMC based on housebound status was denied.